Considering the latest evidence, the biological impact of SRCIN1 on cancer, whether it contributes to tumor progression or acts as an oncogene, seems to be influenced by a range of intermediary proteins specific to various cancer types and subtypes. Here, SRCIN1 is linked to cancer.